Evolution of the neuropathology of Alzheimer's disease
- PMID: 8740983
- DOI: 10.1111/j.1600-0404.1996.tb05866.x
Evolution of the neuropathology of Alzheimer's disease
Abstract
Our knowledge of the etiology and pathogenesis of Alzheimer's disease is limited. The most conspicuous changes seen in the brain are deposits of insoluble proteins in both extracellular and intraneuronal locations. The extracellular deposits consist primarily of a specific A4 amyloid protein. The significance of these deposits remains to be determined, as they are often found in the cerebral cortex of non-demented elderly persons. More telling is the gradual accumulation of insoluble fibrous material within some neurons that consists mainly of abnormally phosphorylated tau protein. Six stages of increasingly severe cortical destruction can be distinguished. Stages I and II are characterized by neurofibrillary changes that are largely confined to the transentorhinal region, whereas stages III and IV are marked by severe involvement of both the entorhinal and transentorhinal regions. Isocortical destruction occurs during stages V and VI. This progression in cortical pathology correlates with the gradual worsening of clinical symptoms.
Similar articles
-
A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.Brain Res. 1999 Feb 13;818(2):383-96. doi: 10.1016/s0006-8993(98)01307-9. Brain Res. 1999. PMID: 10082824
-
The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.Acta Neuropathol. 2000 Jul;100(1):29-35. doi: 10.1007/s004010051189. Acta Neuropathol. 2000. PMID: 10912917
-
Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):70-6. doi: 10.1159/000017104. Dement Geriatr Cogn Disord. 1999. PMID: 10026378 Clinical Trial.
-
Staging of Alzheimer-related cortical destruction.Eur Neurol. 1993;33(6):403-8. doi: 10.1159/000116984. Eur Neurol. 1993. PMID: 8307060 Review.
-
Neuropathological stageing of Alzheimer-related changes.Acta Neuropathol. 1991;82(4):239-59. doi: 10.1007/BF00308809. Acta Neuropathol. 1991. PMID: 1759558 Review.
Cited by
-
Caloric restriction mimetic 2-deoxyglucose maintains cytoarchitecture and reduces tau phosphorylation in primary culture of mouse hippocampal pyramidal neurons.In Vitro Cell Dev Biol Anim. 2015 Jun;51(6):546-55. doi: 10.1007/s11626-015-9867-1. Epub 2015 Feb 13. In Vitro Cell Dev Biol Anim. 2015. PMID: 25678460
-
Tau Exon 10 Inclusion by PrPC through Downregulating GSK3β Activity.Int J Mol Sci. 2021 May 20;22(10):5370. doi: 10.3390/ijms22105370. Int J Mol Sci. 2021. PMID: 34065232 Free PMC article.
-
Transmission of tau pathology induced by synthetic preformed tau filaments.J Neurosci. 2013 Apr 17;33(16):6707-8. doi: 10.1523/JNEUROSCI.0725-13.2013. J Neurosci. 2013. PMID: 23595728 Free PMC article. No abstract available.
-
Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer's Type in Rats.Neurotox Res. 2019 Apr;35(3):621-634. doi: 10.1007/s12640-019-0005-9. Epub 2019 Feb 7. Neurotox Res. 2019. PMID: 30729451
-
Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3.Front Neuroinform. 2019 Feb 19;13:2. doi: 10.3389/fninf.2019.00002. eCollection 2019. Front Neuroinform. 2019. PMID: 30837858 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical